C 
Cardinal Health CAH · USD
Health Care · Health Care Providers & Services · US listing · 🇺🇸 United States
S&P 500
274.29
+0.95%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$254.25bn
FY2017FY2026
Net income
$1.71bn
FY2017FY2026
Free cash flow
$4.53bn
FY2017FY2026
Shareholders' equity
−$2.88bn
FY2017FY2026
Income statement
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $254.25bn | $222.58bn | $226.83bn | $204.98bn | $181.33bn | $162.47bn | $152.92bn | $145.53bn | $136.81bn | $129.98bn |
| Gross profit | $9.77bn | $8.17bn | $7.41bn | $6.89bn | $6.48bn | $6.78bn | $6.87bn | $6.83bn | $7.18bn | $6.54bn |
| Operating income | $2.61bn | $2.27bn | $1.24bn | $752.0m | −$637.0m | $472.0m | −$4.10bn | $2.06bn | $126.0m | $2.12bn |
| Net income | $1.71bn | $1.56bn | $852.0m | $330.0m | −$938.0m | $611.0m | −$3.69bn | $1.36bn | $256.0m | $1.29bn |
| Diluted earnings per share | 7.23 | 6.59 | 3.51 | 1.34 | -3.59 | 2.17 | -12.52 | 4.64 | 0.85 | 4.08 |
Balance sheet
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $57.30bn | $53.12bn | $45.12bn | $43.35bn | $43.88bn | $44.45bn | $40.77bn | $40.96bn | $39.95bn | $40.11bn |
| Cash and short-term investments | $4.86bn | $3.87bn | $5.13bn | $4.08bn | $4.72bn | $3.41bn | $2.77bn | $2.53bn | $1.76bn | $6.88bn |
| Total liabilities | $60.02bn | $55.76bn | $48.33bn | $46.31bn | $44.58bn | $42.66bn | $38.97bn | $34.63bn | $33.89bn | $33.28bn |
| Debt | $2.08bn | $8.53bn | $5.09bn | $4.70bn | $5.32bn | $6.24bn | $6.78bn | $8.03bn | $9.01bn | $10.39bn |
| Shareholders' equity | −$2.88bn | −$2.78bn | −$3.21bn | −$2.96bn | −$709.0m | $1.79bn | $1.79bn | $6.33bn | $6.06bn | $6.81bn |
| Shares outstanding | 237m | 237m | 243m | 246m | 261m | 281m | 295m | 294m | 300m | 316m |
Cash flow
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $5.17bn | $2.40bn | $3.76bn | $2.84bn | $3.12bn | $2.43bn | $1.96bn | $2.72bn | $2.77bn | $1.18bn |
| Capital spending | −$649.0m | −$547.0m | −$511.0m | −$481.0m | −$387.0m | −$400.0m | −$375.0m | −$328.0m | −$384.0m | −$387.0m |
| Free cash flow | $4.53bn | $1.85bn | $3.25bn | $2.36bn | $2.73bn | $2.03bn | $1.58bn | $2.39bn | $2.38bn | $797.0m |
| Dividends paid | −$491.0m | −$494.0m | −$499.0m | −$525.0m | −$559.0m | −$573.0m | −$569.0m | −$577.0m | −$581.0m | −$577.0m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $63.86bn | $60.94bn | $65.44bn | $64.01bn | $60.16bn | $54.88bn | $55.26bn | $52.28bn |
| Gross profit | $2.75bn | $2.50bn | $2.21bn | $2.32bn | $2.20bn | $2.12bn | $1.94bn | $1.90bn |
| Operating income | $729.0m | $509.0m | $707.0m | $668.0m | $428.0m | $730.0m | $549.0m | $568.0m |
| Net income | $394.0m | $399.0m | $471.0m | $450.0m | $239.0m | $506.0m | $400.0m | $416.0m |
| Diluted earnings per share | 1.66 | 1.68 | 1.99 | 1.90 | 1.01 | 2.14 | 1.65 | 1.71 |
| Cash from operations | $1.69bn | $1.82bn | $686.0m | $973.0m | $1.53bn | $2.92bn | −$400.0m | −$1.65bn |
| Capital spending | −$264.0m | −$146.0m | −$131.0m | −$108.0m | −$232.0m | −$126.0m | −$99.0m | −$90.0m |
| Free cash flow | $1.43bn | $1.68bn | $555.0m | $865.0m | $1.29bn | $2.79bn | −$499.0m | −$1.74bn |
| Total assets | $57.30bn | $56.69bn | $58.08bn | $55.23bn | $53.12bn | $49.87bn | $47.00bn | $43.06bn |
| Cash and short-term investments | $4.86bn | $3.94bn | $2.78bn | $4.59bn | $3.87bn | $3.33bn | $3.81bn | $2.87bn |
| Debt | $2.08bn | $8.92bn | $9.03bn | $9.03bn | $8.69bn | $7.68bn | $7.61bn | $5.16bn |
| Shareholders' equity | −$2.88bn | −$2.83bn | −$2.88bn | −$2.88bn | −$2.78bn | −$2.95bn | −$2.99bn | −$3.28bn |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 7.4% | 9.4% | 7.7% |
| Operating income | 51.5% | 40.8% | 0.6% |
| Net income | 73.2% | 22.9% | 1.8% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 3.8% | 3.5% | 3.6% | 4.1% |
| Operating margin | 1.0% | 0.8% | 0.5% | 0.5% |
| Net margin | 0.7% | 0.5% | 0.3% | 0.2% |
Valuation history
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 36.2 | 31.2 | 33.7 | 75.1 | -21.4 | 23.7 | -4.3 | 10.9 | 52.3 | 15.0 |
| Price to sales | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
Market value over time
31 Oct 2016 to 16 Sept 2026, in USD
$22.12bn$55.11bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | 72% | 15% | 27% | 61% | -9% | 4% | 14% | -29% | -13% | -17% |
Dividends and splits
Per share, in the currency the company pays
Paid for 37 years. Last went ex-dividend on 1 Oct 2026.
| FY2027 | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 1.032 | 1.532 | 2.028 | 2.007 | 1.988 | 1.968 | 1.949 | 1.929 |
- 3-for-2 split · 23 Apr 2001
- 3-for-2 split · 2 Nov 1998
- 3-for-2 split · 17 Dec 1996
- 5-for-4 split · 1 Jul 1994
- 5-for-4 split · 1 Oct 1991
- 1.25-for-1 split · 1 Oct 1990
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.